Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

NCT04440358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DEVICE: Exablate BBBD
DRUG: Carboplatin

Sponsor

InSightec